检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵希[1] Zhao Xi(The First Affiliated Hospital of Hunan College of Traditional Chinese Medicine,Hunan Zhuzhou 412000)
机构地区:[1]湖南中医药高等专科学校附属第一医院,湖南株洲412000
出 处:《中国社区医师》2021年第4期71-72,共2页Chinese Community Doctors
摘 要:目的:观察卡培他滨单药维持治疗晚期三阴性乳腺癌患者的效果及对生活质量的影响。方法:2019年1月-2020年1月收治晚期三阴性乳腺癌患者80例,随机分为两组,各40例。对照组应用常规治疗;观察组应用卡培他滨单药治疗。比较两组临床疗效、并发症发生率及生活质量。结果:观察组治疗总有效率及疾病控制率均高于对照组,差异有统计学意义(P<0.05)。观察组生活质量各项评分均优于对照组,差异有统计学意义(P<0.05)。观察组并发症发生率低于对照组,差异有统计学意义(P<0.05)。结论:应用卡培他滨单药治疗晚期三阴性乳腺癌患者,可有效提升治疗效果,为疾病进程的控制提供有效保障,提高患者生活质量。Objective:To observe the effect of capecitabine monotherapy in the treatment of patients with advanced triple-negative breast cancer and its effect on the quality of life of patients.Methods:From January 2019 to January 2020,80 cases of patients with advanced triple-negative breast cancer were enrolled,they were randomly divided into two groups with 40 cases in each group.The control group was treated with conventional therapy,while the observation group was treated with capecitabine monotherapy.The clinical efficacy,incidence of complications and quality of life between the two groups were compared.Results:The total effective rate of treatment and disease control rate in observation group were higher than those in control group,the differences were statistically significant(P<0.05).The scores of quality of life in the observation group were better than those in the control group,the difference was statistically significant(P<0.05).The incidence of complication of observation group was lower than that of control group,the difference was statistically significant(P<0.05).Conclusion:Capecitabine monotherapy in the treatment of patients with advanced triple-negative breast cancer can effectively improve the therapeutic effect,provide effective guarantee for the control of disease process and it also can improve the quality of life of patients.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3